Inventor · disambiguated record
Jennifer E. Adair
Also filed as: ADAIR JENNIFER E
4 granted patents·6 pending applications·25 citations·filing 2016–2022
70Inventor score
Top patents by PatentIndex Score
10 records- 0191US10350245B2Point-of-care and/or portable platform for gene therapyHUTCHINSON FRED CANCER RES·Filed 2016·Granted Jul 16, 2019·21 cites·17 claims
- 0288US10828333B2Point-of-care and/or portable platform for gene therapyHUTCHINSON FRED CANCER RES·Filed 2019·Granted Nov 10, 2020·4 cites·20 claims
- 0367US12442021B2Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapiesFRED HUTCHINSON CANCER CENTER·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 0461US2021052658A1Point-of-care and/or portable platform for gene therapyHUTCHINSON FRED CANCER RES·Filed 2020·Application pending·0 cites
- 0555US11603544B2Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapiesFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Mar 14, 2023·0 cites·20 claims
- 0655US2023159895A1Strategies to assess and/or produce cell populations with predictive engraftment potentialFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 0745US2022025403A1Reduced and minimal manipulation manufacturing of genetically-modified cellsHUTCHINSON FRED CANCER RES·Filed 2019·Application pending·0 cites
- 0839US2020199534A1Therapeutic formulations containing cd34+ stem cells derived from negative selectionHUTCHINSON FRED CANCER RES·Filed 2018·Application pending·0 cites
- 0937US2020009266A1In vivo gene therapy for immune deficienciesHUTCHINSON FRED CANCER RES·Filed 2018·Application pending·0 cites
- 1033US2019345450A1Strategies to assess and/or produce cell populations with predictive engraftment potentialHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jennifer E. Adair files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →